Cargando…

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125289/ http://dx.doi.org/10.1371/journal.pone.0105742

Ejemplares similares

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
Publicado: (2014)

Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
por: Zhang, Zhen-Yu, et al.
Publicado: (2014)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

MBRS-06. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA
por: Natsumeda, Manabu, et al.
Publicado: (2020)

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
por: Kool, Marcel, et al.
Publicado: (2012)

The transcriptional landscape of Shh medulloblastoma
por: Skowron, Patryk, et al.
Publicado: (2021)

Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression
por: Wynn, Daniel T, et al.
Publicado: (2022)

Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019)

Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours
por: Łastowska, Maria, et al.
Publicado: (2015)

Evasion of cell senescence in SHH medulloblastoma
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2016)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2021)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
por: Dang, Mai T., et al.
Publicado: (2023)

Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma
por: Fang, Huangyi, et al.
Publicado: (2023)

Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma
por: Landry, Alexander P., et al.
Publicado: (2021)

Wnt Signaling Activates Shh Signaling in Early Postnatal Intervertebral Discs, and Re-Activates Shh Signaling in Old Discs in the Mouse
por: Winkler, Tamara, et al.
Publicado: (2014)

Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup
por: dos Santos Klinger, Paulo Henrique, et al.
Publicado: (2020)

AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
por: Cai, Jing, et al.
Publicado: (2023)

The Tale of the Three Brothers – Shh, Wnt, and Fgf during Development of the Thalamus
por: Hagemann, Anja I. H., et al.
Publicado: (2012)

Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup
por: Miele, Evelina, et al.
Publicado: (2015)

Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance
por: Lindsey, Janet C., et al.
Publicado: (2014)

Epigenetic Changes in Basal Cell Carcinoma Affect SHH and WNT Signaling Components
por: Brinkhuizen, Tjinta, et al.
Publicado: (2012)

Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
por: Zhang, Jingyu, et al.
Publicado: (2016)

Cranial Nerve Development Requires Co-Ordinated Shh and Canonical Wnt Signaling
por: Kurosaka, Hiroshi, et al.
Publicado: (2015)

Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signalling
por: Maimets, Martti, et al.
Publicado: (2022)

Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019)

Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
por: Caimano, Miriam, et al.
Publicado: (2021)

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
por: Wang, Yan-Xia, et al.
Publicado: (2022)

Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
por: Ocasio, Jennifer Karin, et al.
Publicado: (2022)

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
por: Lee, Chanhee, et al.
Publicado: (2018)

Disruption of rack1 suppresses SHH‐type medulloblastoma formation in mice
por: Liu, Fengjiao, et al.
Publicado: (2021)

BIOL-08. IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA
por: Kunhiraman, Haritha, et al.
Publicado: (2021)

EMBR-19. SHH-DRIVEN MEDULLOBLASTOMA WITH CONCURRENT UNILATERAL RENAL AGENESIS
por: Aaroe, Ashley, et al.
Publicado: (2021)

MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma
por: Kresbach, Catena, et al.
Publicado: (2022)

MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
por: Mynarek, Martin, et al.
Publicado: (2022)

A Cascade of Wnt, Eda, and Shh Signaling Is Essential for Touch Dome Merkel Cell Development
por: Xiao, Ying, et al.
Publicado: (2016)

STIL Endows Oncogenic and Stem-Like Attributes to Colorectal Cancer Plausibly by Shh and Wnt Signaling
por: Pradhan, Tapas, et al.
Publicado: (2021)

Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma
por: Łastowska, Maria, et al.
Publicado: (2019)

Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
por: Azzollini, Jacopo, et al.
Publicado: (2020)

Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
por: Neve, Anuja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3k2hn204n4110kpomqss5mk0r2